193 related articles for article (PubMed ID: 31364156)
1. Quantification of prior impact in terms of effective current sample size.
Wiesenfarth M; Calderazzo S
Biometrics; 2020 Mar; 76(1):326-336. PubMed ID: 31364156
[TBL] [Abstract][Full Text] [Related]
2. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
3. An adaptive trial design to optimize dose-schedule regimes with delayed outcomes.
Lin R; Thall PF; Yuan Y
Biometrics; 2020 Mar; 76(1):304-315. PubMed ID: 31273750
[TBL] [Abstract][Full Text] [Related]
4. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.
Hobbs BP; Carlin BP; Mandrekar SJ; Sargent DJ
Biometrics; 2011 Sep; 67(3):1047-56. PubMed ID: 21361892
[TBL] [Abstract][Full Text] [Related]
6. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Harun N; Liu C; Kim MO
Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
[TBL] [Abstract][Full Text] [Related]
7. Bayesian clinical trial design using historical data that inform the treatment effect.
Psioda MA; Ibrahim JG
Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
[TBL] [Abstract][Full Text] [Related]
8. An adaptive power prior for sequential clinical trials - Application to bridging studies.
Ollier A; Morita S; Ursino M; Zohar S
Stat Methods Med Res; 2020 Aug; 29(8):2282-2294. PubMed ID: 31729275
[TBL] [Abstract][Full Text] [Related]
9. Bayesian design of noninferiority trials for medical devices using historical data.
Chen MH; Ibrahim JG; Lam P; Yu A; Zhang Y
Biometrics; 2011 Sep; 67(3):1163-70. PubMed ID: 21361889
[TBL] [Abstract][Full Text] [Related]
10. Determining the effective sample size of a parametric prior.
Morita S; Thall PF; Müller P
Biometrics; 2008 Jun; 64(2):595-602. PubMed ID: 17764481
[TBL] [Abstract][Full Text] [Related]
11. SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials.
Yang P; Zhao Y; Nie L; Vallejo J; Yuan Y
Biometrics; 2023 Dec; 79(4):2857-2868. PubMed ID: 37721513
[TBL] [Abstract][Full Text] [Related]
12. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
13. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Sawamoto R; Oba K; Matsuyama Y
Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
[TBL] [Abstract][Full Text] [Related]
14. Borrowing strength with nonexchangeable priors over subpopulations.
Leon-Novelo LG; Bekele BN; Müller P; Quintana F; Wathen K
Biometrics; 2012 Jun; 68(2):550-8. PubMed ID: 22040065
[TBL] [Abstract][Full Text] [Related]
15. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
Quan H; Zhang B; Lan Y; Luo X; Chen X
Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
[TBL] [Abstract][Full Text] [Related]
16. Bayesian selective response-adaptive design using the historical control.
Kim MO; Harun N; Liu C; Khoury JC; Broderick JP
Stat Med; 2018 Nov; 37(26):3709-3722. PubMed ID: 29900577
[TBL] [Abstract][Full Text] [Related]
17. Modified power prior with multiple historical trials for binary endpoints.
Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
[TBL] [Abstract][Full Text] [Related]
18. Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strata.
Li M; Liu R; Lin J; Bunn V; Zhao H
J Biopharm Stat; 2020 Sep; 30(5):806-820. PubMed ID: 32129133
[TBL] [Abstract][Full Text] [Related]
19. Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach.
Qi H; Rizopoulos D; van Rosmalen J
Res Synth Methods; 2023 May; 14(3):396-413. PubMed ID: 36625478
[TBL] [Abstract][Full Text] [Related]
20. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]